XML 20 R8.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Operating activities:    
Net income $ 87,924 $ 85,834
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation of premises and equipment, and amortization 4,674 4,562
Amortization of intangible assets 1,479 3,090
Provision for credit losses 9,063 4,670
Amortization of investment securities premium, net 1,434 511
Loss on sale of investment securities 3,266 43
Originations of loans for sale (54,156) (48,197)
Proceeds from sale of loans originated for sale 52,825 47,476
Gain on sale of loans (1,174) (1,198)
Change in fair market value of mortgage servicing rights 297 468
Gain on transfer of loans to foreclosed assets 0 (38)
(Gain) loss on sale of foreclosed assets (3) 26
Change in the market value of foreclosed assets 3 262
Operating lease expense payments (4,583) (4,658)
Loss on disposal of fixed assets 111 12
Increase in cash value of life insurance (2,533) (2,420)
Gain on life insurance death benefit (1,209) 0
(Gain) loss on marketable equity securities (72) (121)
Equity compensation vesting expense 3,660 3,550
Gain on extinguishment of junior subordinated debt (2,504) 0
Change in:    
Interest receivable 2,684 3,707
Interest payable (3,260) 3,219
Amortization of operating lease ROUA 4,441 4,481
Other assets and liabilities, net (3,534) (19,812)
Net cash from operating activities 98,833 85,467
Investing activities:    
Proceeds from maturities of securities available for sale 266,581 315,627
Proceeds from maturities of securities held to maturity 16,290 16,074
Proceeds from sale and calls of available for sale securities 58,512 31,534
Purchases of securities available for sale (98,091) (122,873)
Loan origination and principal collections, net (249,761) 107,690
Proceeds from sale of other real estate owned 103 149
Purchases of premises and equipment (4,585) (3,250)
Proceeds from the payment of life insurance benefits 7,312 0
Net cash from (used by) investing activities (3,639) 344,951
Financing activities:    
Net change in deposits 246,885 203,053
Net change in other borrowings (72,571) (365,815)
Repurchase of common stock (22,326) (13,651)
Dividends paid (33,365) (32,766)
Retirement of junior subordinated debt, net (59,953) 0
Exercise of stock options 0 174
Net cash from (used by) financing activities 58,670 (209,005)
Net change in cash and cash equivalents 153,864 221,413
Cash and cash equivalents, beginning of period 144,956 98,701
Cash and cash equivalents, end of period 298,820 320,114
Supplemental disclosure of noncash activities:    
Unrealized gain on securities available for sale 67,443 51,383
Market value of shares tendered in-lieu of cash to pay for exercise of equity and/or related taxes 1,072 1,168
Obligations incurred in conjunction with leased assets 6,000 2,226
Life insurance receivable 103 0
Loans transferred to foreclosed assets 2,747 458
Supplemental disclosure of cash flow activity:    
Cash paid for interest expense 95,069 99,233
Cash paid for income taxes $ 22,600 $ 27,200